Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q2 2014 · 10-Q
Revenue$303.00$303.00−32.8% vs Q2 2013 Net Income-$16.02K-$16.02KN/M vs Q2 2013 EPS Diluted$0.00$0.00— vs Q2 2013 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Margins · derivedGross margin100.0%±0.0 pt vs Q2 2013
Operating margin-5286.8%−2006.3 pt vs Q2 2013
Net margin-5286.8%−1046.9 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 18, 2014 · 49 d after period end